Oneview Healthcare Details Epic Certification Push as Recurring Revenue Climbs 13%

Oneview Healthcare's H1 2026 results show recurring revenue up 13% to €4.3m, gross margin expanding to 70%, and a freshly opened Epic-certified channel that's already reactivating stalled pipeline — here's what investors need to know.
By Josua Ferreira -
  • Recurring revenue grew 13% to €4.3m in H1 2026, while gross margin expanded nine percentage points to 70% — gross profit held flat at €3.8m despite €0.8m less total revenue, confirming the deliberate mix shift is working.
  • Epic certification of Bedside Hub in May 2026 has already reactivated 9 previously stalled pipeline opportunities, with 16 active EpicTV opportunities now representing 19,860 licensed beds.
  • The Baxter reseller funnel stands at 131 open opportunities covering 36,375 licensed beds, including addition to a national care communication agreement with a top-10 US health system spanning 85+ hospitals and 15,000+ beds.
  • Cash of €7.2m at 30 June rises to €11.4m pro forma once the A$7m Tranche 2 placement clears shareholder approval at the Q4 2026 AGM, extending the runway available to bridge to breakeven.
  • Operating cash outflow fell 15% to €4.1m and cash operating expenses dropped 6% to €7.8m, with management targeting 3–4 new Bedside Hub logo wins and first Ovie AI pilot feedback in H2 2026.
Summarise with AI:

In its H1 2026 results presentation, delivered 27 August 2026 by Chief Executive Officer James Fitter and Chief Financial Officer Darragh Lyons, Oneview Healthcare (ASX) outlined a strategic shift toward what management framed as a “path to scalable growth.”

The headline story centred on recurring revenue climbing 13% to €4.3m, gross margin expanding to 70%, and the opening of a new Epic-certified revenue channel. Operating cash outflow fell 15% to €4.1m, while the company closed the half with cash of €7.2m (€11.4m pro forma for the second placement tranche).

H1 2026 financial performance at a glance

The financial picture management presented reflected a deliberate mix shift. Total revenue fell 14% to €5.5m, but this was driven by a lower non-recurring contribution as the company prioritised higher-margin recurring revenue. Notably, gross profit held flat at €3.8m despite €0.8m less revenue.

Metric (€m) H1 2026 H1 2025 Change
Recurring revenue 4.3 3.8 +13%
Non-recurring revenue 1.2 2.5 −54%
Total revenue 5.5 6.3 −14%
Gross profit 3.8 3.8 0%
Gross margin 70% 61% +9pts
Operating EBITDA loss (4.0) (4.5) −11%

Cash operating expenses fell 6% to €7.8m, sitting 10% below the H2 2024 peak as savings from the June 2025 restructuring flowed through the base. Combined with margin expansion, this cost discipline narrows the path to breakeven.

Capital position strengthened by the March placement

The balance sheet reflected proceeds from a two-tranche institutional placement raising A$19m (approximately €11.4m) in gross proceeds, secured in March 2026. Tranche 1 (A$12m) settled on 24 March, while Tranche 2 (A$7m / €4.2m) remains subject to shareholder approval at the AGM scheduled during Q4 2026.

The A$19m institutional placement secured in March 2026 was upsized from its original target due to strong demand from existing and new international investors, with proceeds earmarked for customer deployment acceleration, Ovie AI development, and balance sheet strengthening to meet US health system vendor requirements.

Cash of €7.2m at 30 June was up 56% on 31 December 2025, rising to €11.4m on a pro forma basis including the Tranche 2 proceeds. Net assets stood at €6.4m, up 73% since December.

Commercial momentum: Epic certification opens a new channel

The strategic heart of the presentation was the launch of Bedside Hub in May 2026, following certification by Epic. The product delivers Epic MyChart Bedside TV on Oneview healthcare-grade hardware with cloud-based device management, offering a lower-cost entry point into Epic-centric health systems.

The Bedside Hub launch in May 2026 came with an active pipeline already forming from pre-certification inquiries, including a named 1,100-bed opportunity already in contract negotiations at the time of certification.

The dual-market commercial model

Management outlined two routes to market. The CXP platform targets smart-room buyers, delivering the full Care Experience Platform with deep integrations that management described as the commercial moat. Bedside Hub targets Epic-first buyers with a lower-cost entry point.

Both are sold Direct and through Baxter as value-added reseller. Management noted that 43.7% of US acute care hospitals run on Epic, representing 56.9% of beds in 2025.

Pipeline building across both channels

Commercial highlights presented across both channels included:

  • Four new logos in contract negotiation (1 Direct, 1 via Baxter, 2 via Epic Bedside Hub)

  • Addition to Baxter’s national care communication agreement with the group purchasing organisation of a top-10 US health system (85+ hospitals, 15k+ beds)

  • A Baxter funnel of 131 open opportunities representing 36,375 licensed beds, with 37 at design stage or beyond

  • A Bedside Hub pipeline of 16 active EpicTV opportunities representing 19,860 licensed beds, of which 9 were previously stalled and reactivated by certification

  • A first enterprise pilot: a 15-bed EpicTV pilot across three hospitals of a top-20 health system, commencing September

  • A first-ever invitation to Epic’s User Group Meeting in Madison, producing 50+ conversations and 10 demonstrations in the two weeks prior

Management indicated that certification is reactivating dormant pipeline and providing ecosystem credibility that Oneview could not otherwise acquire.

Oneview Dual-Market Commercial Pipeline Dashboard

Installed base and market backdrop

The installed base grew to 15,092 live endpoints at 30 June, with 693 units deployed and 481 decommissioned in the half. Average recurring revenue per new endpoint was 59% higher than on those decommissioned.

In Australia and New Zealand, the sales pipeline has doubled, from 3 active bids in January to 8 today, with 4 of the 8 for hospitals under construction. Management noted that US procurement pressure, including EpicTV evaluations and tighter federal funding, is temporarily slowing full-platform decisions while increasing Bedside Hub’s relevance.

Sponsored

What is Bedside Hub and why does it matter?

Epic is the electronic health record (EHR) system used across 43.7% of acute hospitals. Certification means Epic validated Oneview to run its MyChart Bedside TV application on Oneview’s own healthcare-grade hardware.

For cost-conscious hospitals, a lower-priced entry point carries greater weight when capital budgets tighten. From an investment perspective, Bedside Hub provides a lower-cost entry point into Epic accounts and expands the addressable market.

Sponsored

Product innovation and the road to breakeven

Innovation delivered in H1

Management detailed four product deliveries during the half:

  1. Bedside Hub — Epic-certified and launched May 2026

  2. New front end — substantially complete, with first deployments scheduled from September

  3. Ovie — evolving into an agentic intelligence layer designed to orchestrate patient and staff workflows, with initial pilots planned during 2026

  4. Data and analytics — advanced utilisation dashboards shipped in H1

AI-enabled development

Management highlighted the integration of AI into the delivery model, supported by governance controls. Key metrics presented included approximately 85% of code written by AI agents (with human-in-the-loop review), 1.7x feature development, and around 5x faster bug root-cause investigation, underpinned by ISO 42001-aligned governance. Management indicated this shortens deployment timelines and improves operating leverage.

The US$50bn opportunity and competitive moat

The presentation positioned the US$50bn Rural Health Transformation Program (FY2026–FY2030) as policy alignment rather than guidance, explicitly noting that no allocations or revenue are assumed. The programme funds telehealth, remote monitoring, digital infrastructure and workforce productivity, capabilities management stated the platform already delivers.

On the competitive moat, management pointed to deep integrations, high switching costs from 15,092 embedded endpoints, 3 of the Top 25 US hospitals as customers, and ISO 27001, ISO 27701 and ISO 42001 certifications.

Management stated the strategic priority is continued progress to bridge to cash flow breakeven.

H2 2026 outlook and priorities

Management outlined the forward roadmap for H2 2026, grouped by theme:

  • Commercial: convert late-stage opportunities; target 3-4 new Bedside Hub logo wins; drive expansions across the existing base

  • Financial: sustain the strong ARR growth trajectory; continue optimising the operating cost base

  • Product: first deployments of the new front end from September; customer feedback from the Ovie pilots

  • Operations: first deployments of Bedside Hub; commence initial projects with the top-10 health system

The strategic through-line management presented was continued progress bridging to cash flow breakeven, underpinned by margin expansion, cost discipline and the new Epic channel.

Sponsored

Don’t Miss the Next Healthcare Breakout on the ASX

Big News Blast delivers FREE breaking ASX healthcare news directly to your inbox within minutes of release, complete with in-depth analysis already done. Join 20,000+ investors who stay ahead of the market the moment announcements hit. Click the “Free Alerts” button to start receiving real-time coverage today.


Frequently Asked Questions

What were Oneview Healthcare's H1 2026 results?

Oneview Healthcare reported H1 2026 recurring revenue of €4.3m, up 13%, with gross margin expanding to 70% from 61%. Total revenue fell 14% to €5.5m as the company deliberately reduced lower-margin non-recurring work, while operating cash outflow improved 15% to €4.1m.

What is Bedside Hub and why is it significant for Oneview Healthcare?

Bedside Hub is an Epic-certified product launched in May 2026 that delivers Epic MyChart Bedside TV on Oneview's healthcare-grade hardware, offering a lower-cost entry point into Epic-centric hospitals. It opens Oneview to 43.7% of US acute care hospitals that run on Epic, a market segment previously inaccessible through the full CXP platform alone.

How much cash does Oneview Healthcare have after its H1 2026 results?

Oneview Healthcare held €7.2m in cash at 30 June 2026, rising to €11.4m on a pro forma basis once the A$7m Tranche 2 of its March 2026 institutional placement clears shareholder approval at the Q4 2026 AGM.

What is Oneview Healthcare's path to breakeven?

Management is targeting breakeven through a combination of recurring revenue growth, gross margin expansion (now at 70%), and cost discipline — cash operating expenses are already 10% below the H2 2024 peak. The new Epic-certified Bedside Hub channel and Baxter reseller pipeline are the primary commercial levers for accelerating ARR growth toward that goal.

What is the Baxter reseller relationship and how big is the pipeline?

Baxter acts as a value-added reseller for Oneview's products and currently has a funnel of 131 open opportunities representing 36,375 licensed beds, with 37 at design stage or beyond. Oneview was also added to Baxter's national care communication agreement with a top-10 US health system covering more than 85 hospitals and 15,000 beds.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher